Certain 1-azabicyclo[2.2.1]heptanes useful as muscarinic receptor antagonists
AssigneePfizer Inc.
InventorsDavid Alker, Peter E. Cross, John E. G. Kemp
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorsDavid Alker, Peter E. Cross, John E. G. Kemp
Estimating the term…
MUSCARINIC RECEPTOR ANTAGONISTS OF THE FOLLOWING FORMULAE: ##STR1## Muscarinic receptor antagonists, useful especially in the treatment of irritable bowel syndrome, of formula (IA) or (IB) or a pharmaceutically acceptable salt thereof, where R.sup.2 and R.sup.3 are each independently H, halo or C.sub.1 -C.sub.4 alkyl; m is 0, 1 or 2; n is 1, 2 or 3; Y is a direct link, O or S; with the proviso that when n is 1, Y is a direct link; Het is a group of formula (A) or (B), where p is 0, 1 or 2, q is 1, 2 or 3, and r is 0, 1, 2 or 3, with the proviso that the sum of p, q and r is at least 3, the N atom of "Het" being attached to the group (CH.sub.2).sub.n in formula (IA) and to the H atom in formula (IB); and R.sup.1 is a group of formula (a), (b) or Het.sup.1, where R.sup.4 and R.sup.5 are each independently H, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, --(CH.sub.2).sub.t OH, halo, trifluoromethyl, cyano, --(CH.sub.2).sub.t NR.sup.6 R.sup.7, --CO(C.sub.1 -C.sub.4 alkyl), --OCO(C.sub.1 -C.sub.4 alkyl), CH(OH)(C.sub.1 -C.sub.4 alkyl), --C(OH)(C.sub.1 -C.sub.4 alkyl).sub.2, --SO.sub.2 NH.sub.2, --(CH.sub.2).sub.t CONR.sup.6 R.sup.7 or --(CH.sub.2).sub.t COO(C.sub.1 -C.sub.4 alkyl); R.sup.6 and R.sup.7 are each independently H or C.sub.1 -C.sub.4 alkyl; t is 0, 1 or 2; X and X.sup.1 are each independently O or CH.sub.2 ; s is 1, 2 or 3; and Het.sup.1 is pyridyl, pyrazinyl or thienyl.
A compound of the formula:
Dependencies are inferred from the claim text.